Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Russell

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Lancet. Respiratory Medicine|November 30, 2024
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, et al.
ERJ Open Research|May 15, 2024
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19Steven P Cass, Dan V Nicolau, Jonathan R Baker, et al.
The European Respiratory Journal|January 24, 2009
Leukotriene B4 release by human lung macrophages via receptor- not voltage-operated Ca2+ channelsT K Finney-Hayward, P Bahra, S Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancerV K Kasturi, M P Dearing, S C Piscitelli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2025
Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO)Rod Hughes, Wayne Brailsford, João Ferreira, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 12, 2026
Sociodemographic Determinants of Hospitalized Exacerbations in Exposure-Defined COPD Phenotypes: A Nationwide Prospective Cohort Study in ChinaZhoude Zheng, Xingyao Tang, Wei Li, et al.
American Journal of Respiratory Cell and Molecular Biology|October 22, 2009
Expression of transient receptor potential C6 channels in human lung macrophagesTricia K Finney-Hayward, Mariana Oana Popa, Parmjit Bahra, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancerG L Shaw, A F Gazdar, R Phelps, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a reviewRobert A Wise, Mona Bafadhel, Courtney Crim, et al.
Journal of Asthma and Allergy|March 2, 2026
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize StudyChristian Gessner, Richard E K Russell, Timm Greulich, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Lancet. Respiratory Medicine|November 30, 2024
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trialSanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, et al.
ERJ Open Research|May 15, 2024
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19Steven P Cass, Dan V Nicolau, Jonathan R Baker, et al.
The European Respiratory Journal|January 24, 2009
Leukotriene B4 release by human lung macrophages via receptor- not voltage-operated Ca2+ channelsT K Finney-Hayward, P Bahra, S Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancerV K Kasturi, M P Dearing, S C Piscitelli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2025
Phase 2a, Randomized Trial of Mitiperstat Versus Placebo in Patients with COPD at High Risk of Exacerbation (CRESCENDO)Rod Hughes, Wayne Brailsford, João Ferreira, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 12, 2026
Sociodemographic Determinants of Hospitalized Exacerbations in Exposure-Defined COPD Phenotypes: A Nationwide Prospective Cohort Study in ChinaZhoude Zheng, Xingyao Tang, Wei Li, et al.
American Journal of Respiratory Cell and Molecular Biology|October 22, 2009
Expression of transient receptor potential C6 channels in human lung macrophagesTricia K Finney-Hayward, Mariana Oana Popa, Parmjit Bahra, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancerG L Shaw, A F Gazdar, R Phelps, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Discordant diagnostic criteria for pneumonia in COPD trials: a reviewRobert A Wise, Mona Bafadhel, Courtney Crim, et al.
Journal of Asthma and Allergy|March 2, 2026
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize StudyChristian Gessner, Richard E K Russell, Timm Greulich, et al.
Pageof 6